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Summary. This study explored the evolutionary mechanism by which the clinical isolate PA110514 yields the imipenem-
resistant derivative PA116136. Both isolates were examined by PFGE and SDS-PAGE, which led to the identification of a
new insertion sequence, ISPa133. This element was shown to have distinct chromosomal locations in each of the original iso-
lates that appeared to explain the differences in imipenem susceptibilty. In strain PA110514, ISPa133 is located 56 nucleotides
upstream of the translational start codon, which has no effect on expression of the porin OprD. However, in strain PA116136
ISPa133 it is located in front of nucleotide 696 and, by interrupting the coding region, causes a loss of OprD expression, thus
conferring imipenem resistance. In vitro experiments mimicking the natural conditions of selective pressure yielded imipen-
em-resistant strains in which ISPa133 similarly interrupted oprD. A mechanism is proposed whereby ISPa133 acts as a mobile
switch, with its position in oprD depending on the degree of selective pressure exerted by imipenem. [Int Microbiol 2011;
14(1):51-58]
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Introduction
Infections by Pseudomonas aeruginosa are a serious clinical
problem, particularly in immune compromised hosts in hos-
pital settings [9,29,33]. Moreover, the treatment of these
infections is often difficult because of the limited number of
effective antimicrobial agents, due to the intrinsic resistance
of P. aeruginosa strains and their different modes of growth
[10]. These properties reflect the synergy between the bac-
terium’s low outer-membrane permeability [2,6,38], its chro-
mosomally encoded AmpC β-lactamase [14], and its broadly
specific drug efflux pump [11,17,22,23]. Furthermore, P. ae-
ruginosa readily acquires resistance to most antimicrobials
through mutations in its chromosomal genes and through
extrachromosomal elements carrying resistance determi-
nants [14,25]. Although there are several antimicrobials (car-
bapenems, cefepime, ceftazidime, tobramycin and amikacin)
that continue to be effective against P. aeruginosa, in the last
few years the bacterium’s increasing resistance to many others
has been reported [4,13,18,28,30]. 
Carbapenems are a class of β-lactam antibiotics with
good antimicrobial activity against P. aeruginosa but the
emergence and spread of acquired carbapenem resistance in
this species have challenged the success of therapeutic and
control efforts. Since carbapenems, especially imipenen, are
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widely used in the clinical setting [26], investigation of the
molecular mechanisms leading to resistance is crucial.
Imipenem resistance can involve low permeability, the activ-
ity of an inducible β-lactamase [15], and multidrug efflux
systems, but the most widely accepted mechanism involves
the loss of the porin OprD from the outer membrane [37],
which can occur at the transcriptional or translational level or
through the emergence of mutations in the oprD gene [20].
For example, in one report, the down-regulation of oprD
transcription in clinical isolates of P. aeruginosa was shown
to have occurred by a mechanism involving inactivation of
the gene due to the presence of insertion sequence elements
(IS) [36]. Additional mechanisms of carbapenem resistance
include repressed OprD expression, as is the case in nfxC-
type mutants, which simultaneously overexpress the MexEF-
oprN efflux pump. 
The present study resulted from the isolation of two
strains of P. aeruginosa from the same patient in the course
of a chronic respiratory infection. The first strain was
obtained soon after the patient was admitted to the University
Hospital of Bellvitge (L’Hospitalet, Barcelona, Spain). The
infection was successfully treated with imipenem. The sec-
ond strain was obtained 6 days later, from the patient’s rec-
tum. Pulsed-field gel electrophoresis (PFGE) profiles of the
two isolates were identical, as were the results of biochemi-
cal tests aimed at their identification. However, determina-
tion of antibiotics susceptibility demonstrated that the iso-
lates were identical for all antibiotics tested except imipen-
em: the first isolate was imipenem susceptible whereas the
second was imipenem resistant. Thus, aim of this study was
to search for underlying changes in the isolates’ DNA that
could account for the difference in imipenem susceptibility,
starting from the hypothesis that resistance was mediated by
a loss of OprD expression on the outer membrane. 
Materials and methods
Bacterial strains. The two studied clinical isolates of P. aeruginosa
were isolated from a patient at the Servei de Microbiologia of the Hospital
Universitari de Bellvitge. PA110514 was isolated before imipenem treat-
ment was started, and strain PA116136 after the patient had received the full
course of the antibiotic. P. aeruginosa PA9 was used as the positive control
for amplification of the oprD gene. Strains PA132325 and PA138635, sus-
ceptible and resistant to imipenem, respectively, were used as controls in
preparing extracts of outer membrane proteins (OMPs). P. aeruginosa
strains PAFL2, PAFL4, PAFL8, PAFL12, and PAFL16 are the resistant
mutants obtained in this study. All of the bacterial strains were cultured in
trypticase soy broth (TSB) or on trypticase soy agar (TSA). Bacteriological
media were purchased from Scharlab (Barcelona, Spain). 
Pulsed-field gel electrophoresis. To compare the different strains,
PFGE was carried out as follows: DNA was extracted and purified as
described elsewhere [28,31]. SpeI, a low-frequency restriction enzyme, was
used according to the manufacturer’s specifications (New England Biolabs,
Beverly, MA, USA). The SpeI DNA restriction fragments were separated in
a CHEF-DR III unit (Bio Rad, Hercules, CA, USA) for 20 h at 14ºC and 6
Volts/cm, with pulse times ranging from 0.5 to 25 s. Strain relatedness was
assigned in accordance with published criteria [32]. Pseudomonas aerugi-
nosa PAO1 was used as the control in sequence analysis (accession number
Z14065.1)
Minimum inhibitory concentration (MIC) determinations.
Antimicrobial susceptibility was tested using the microdilution method, with
Mueller-Hinton broth (Scharlab, Barcelona, Spain), according to the guide-
lines of the Clinical and Laboratory Standards Institute (CLSI). The follow-
ing antimicrobials were tested: piperacillin, piperacillin/tazobactam, ticar-
cillin, aztreonam, gentamicin, tobramicin, amikacin, trimethoprim/sulfame-
toxazol, ciprofloxacin, ofloxacin, ceftazidime, cefepime, imipenem, and
meropenem. The antibiotics were purchased from Sigma Chemical Co. (St
Louis, MO, USA).
Outer membrane preparations and SDS-PAGE. Whole bacter-
ial proteins and OMPs were obtained as described elsewhere [24,27]. SDS-
PAGE was performed, using a modification of the method of Laemmli, in a
Bio-Rad apparatus (Mini-Protean II). Gels were stained with 0.25%
Coomassie brilliant blue, destained, and then dried on a gel dryer (Biorad
543) [8,12].
Gene oprD amplification. To obtain P. aeruginosa genomic DNA, 5
ml of Luria broth inoculated with a single colony was incubated overnight at
37°C. Bacteria were harvested by centrifugation and suspended in 180 μl of
ATL buffer from the DNeasy Tissue kit (Qiagen, Germany), which was used
for DNA purification following the manufacturer’s instructions. A modified
version of the PCR assay previously described [36] was used to amplify
oprD. Reaction mixtures had a final volume of 50 μl and contained 2 μl
(1/10th volume) of genomic DNA, 0.5 μM of the OprDSEQF1 forward
primer (5′-CTACGCAGATGCGACATGC-3′), 0.5 μM of the OprDSEQR1
reverse primer (5′-CCTTTATAGGCGCGTTGCC-3′) (Invitrogen, USA), 1 U
of Taq DNA polymerase (Fermentas, Vilnius, Lithuania), 0.2 mM of each
deoxynucleoside triphosphate (Fermentas, Lithuania), 1× PCR buffer, and 2
mM MgCl2. Amplification was achieved in a Techne (Staffordshire, UK)
thermocycler model TC-312 during 25 cycles, each consisting of 30 s at
95°C, 30 s at 56°C, and 2 min at 72°C. Final extension was performed at
72°C for 10 min. PCR products were separated by agarose-gel (1.5% w/v)
electrophoresis in Tris-borate buffer (TBE) at 9 Volts/cm for 1.5 h and visu-
alized using ethidium bromide. 
DNA sequencing and analysis of sequence data. Sequence
data for oprD were obtained by using the primers OprDSEQF1 and
OprDSEQR1. PCR products were purified with the MinElute PCR purifi-
cation kit (Qiagen, Germany) prior to sequencing. The ABI PRISM
BigDye Terminator (version 3.1) Cycle Sequencing Ready Reaction kit
and ABI PRISM(R) 3700 DNA analyzer were used (Applied Biosystems,
USA). Database searches were conducted using the basic local alignment
search tool (BLAST) [1] and multiple alignments carried out with
CLUSTAL W [34]. 
In vitro generation of imipenem-resistant mutants of
Pseudomonas aeruginosa. Approximately 105 P. aeruginosa
PA110514 cells were used to inoculate 20 ml of MHB medium with imipen-
em concentrations ranging from 0.5 to 16 μg/ml. After 24 h of incubation at
37°C, resistant derivatives (MICs = 6–16 μg/ml) were selected by spreading
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0.01 ml of the overnight culture onto MHA plates (Scharlab, Barcelona,
Spain) containing the appropriate concentration of imipenem. Repeated
exposure to the antibiotic was continued with the most resistant derivatives
until an increase in the minimum inhibitory concentration (MIC) of imipen-
em to 16 μg/ml was achieved.
Nucleotide sequences accession numbers. The nucleotide
sequences reported herein have been submitted to GenBank databases. The
accession numbers for the ISPa133 found in strains PA110514 and
PA116136 are FJ387165.2 and FJ387166.2, respectively. 
Results
Minimum inhibitory concentration determina-
tions. Antimicrobial susceptibilities were determined in
MIC tests, with the results shown in Table 1. P. aeruginosa
strain PA110514 was found to be susceptible to all tested
antibiotics while P. aeruginosa strain PA116136 was resistant
to trimethoprim/sulfamethoxazole and imipenem. 
Outer-membrane protein profile. Electrophoretic
comparisons of OMPs from both strains demonstrated, as
expected, that the susceptible strain, P. aeruginosa
PA110514, but not the resistant strain, PA116136, showed a
visible band corresponding to the porin OprD in the outer
membrane (Fig. 1). To investigate the mechanism responsi-
ble for the loss of OprD expression, the oprD genes of both
strains were amplified and sequenced and their sequences
compared. 
Gene oprD amplification. The amplicons obtained
from the oprD gene region of strains PA110514 and
PA116136 were larger than that of strain PA9 used as positive
control (Fig. 2). The predicted length of oprD is 1586 bp,
while the amplicons from PA110514 and PA116136 were
3000 and 2000 bp, respectively. Sequence analysis of both
amplicons revealed the presence of a long insert, approxi-
mately 1300 bp, with a 59.6% G + C content. The insert, des-
ignated ISPa133, showed high homologies with the mobile
elements of the IS3 family of insertion sequences. The simi-
larities were not only in terms of the length of the ISPa133,
which for members of the IS3 family is typically between
1200 and 1550 bp, but due to the presence of two character-
istic open reading frames (ORF), orfA and orfB, which, unusu-
ally, did not overlap (Fig. 3). The insertion element was
flanked by 25-bp terminal inverted repeats (IRs), with TG at
the 5′ end and CA at the 3′ end, as in other members of the
IS3 family. Another general feature of IS elements is that, on
insertion, most generate short directly repeated sequences
(DR) of the target DNA flanking the IS, but these were not
detected in ISPa133.
The first ORF (orfA) encodes a transposase (Fig. 3). In
the search for conserved domains [16], we determined that
CARBAPEM RESISTANCE IN P. AERUGINOSA
Table 1. Susceptibilities to antimicrobial agents tested against Pseudomonas aeruginosa PA110514 and PA116136
Strain  PA110514 Strain  PA116136
Antibiotics MIC* Susceptibility MIC Susceptibility
piperacillin <16 S <16 S
piperacillin/tazobactam <16 S <16 S
ticarcillin <16 S <16 S
aztreonam 2 S 2 S
gentamicin <4 S <4 S
tobramicin <4 S <4 S
amikacin <8 S <8 S
trimethoprim/sulfametoxazol <2/38 S >2/38 R
ciprofloxacin <0.12 S <0.12 S
ofloxacin <0.5 S <0.5 S
ceftazidime <1 S <1 S
cefepime <1 S <1 S
imipenem <1 S >8 R
meropenem <4 S <4 S
*MICs are expressed in μg/ml.
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the protein includes a helix-turn-helix motif (HTH), a family
of DNA-binding domains unique in bacteria, and that it
showed high identity to the transposase 8 family, some of
which are members of the IS3 family. The second ORF, orfB,
encodes the central catalytic domain of an integrase from the
rve super-family [http://pfam.sanger.ac.uk/family PF00665].
Integrase mediates the integration of a DNA copy of the viral
genome into the host chromosome. The enzyme is composed
of three domains. The amino-terminal zinc-binding domain
(pfam02022) is the central catalytic domain. The carboxyl
terminal domain is a non-specific DNA binding domain
(pfam00552). The catalytic domain acts as an endonuclease
when two nucleotides are removed from the 3′ ends of the
blunt-ended viral DNA resulting from reverse transcription.
This domain also catalyzes the DNA-strand-transfer reaction
of the 3′ ends of the viral DNA to the 5′ ends of the integra-
tion site. 
While the large insert located in PA116136 was 99%
identical to that found in PA110514, its location in oprD was
different. In PA110514, ISPa133 was located 56 nucleotides
upstream of the translational start codon, but in PA116136 it
occurred immediately before nucleotide position 697, effec-
tively replacing this nucleotide and causing the removal of
the first 232 amino acids of the porin OprD (Fig. 4). 
In vitro generation of imipenem-resistant
mutants of Pseudomonas  aeruginosa. Repeated
exposure of P. aeruginosa PA110514 to imipenem allowed
the selection of several defective OprD mutants. When oprD
was amplified using DNA from cultures resistant to imipen-
RUIZ-MARTÍNEZ ET AL.
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Fig. 1. Outer membrane protein profiles. Black arrows indicate the position of OprD. Lane 1: SDS-PAGE standards, (Low
Range, Bio-RAD, USA); lane 2: strain PA110514; lane 3: strain PA116136; lane 4: strain PA138635 (imipenem-resistant
control); lane 5: strain PA132325 (imipenem-susceptible control).
Fig. 2. PCR amplification products obtained with primers OprDSEQF1
and OprDSEQR1. Fragments were separated by electrophoresis through
a 1.5% agarose gel. Lane 1: GeneRuler 1 kb DNA Ladder (Fermentas,
Vilnius, Lithuania). Lane 2: strain PA110514. Lane 3: strain PA116136.
Lane 4: strain PAFL2. Lane 5: strain PAFL4. Lane 6: strain PAFL8.
Lane 7: strain PAFL12. Lane 8: strain PAFL16. Lane 9: strain PA9, used
as positive control.
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em concentrations 2, 4, 8, 12, and 16 times higher than the
MIC value for PA110514, an amplicon of 2000 bp was
obtained, i.e., identical in size to the amplicon of the resistant
clinical isolate PA116136. Sequencing of the amplicon
revealed the presence of ISPa133. The position of the inser-
tion element in the mutants was not the same as in PA110514
and PA116136. In the mutant strain PAFL2, ISPa133 was
located immediately before nucleotide position 667, replac-
CARBAPEM RESISTANCE IN P. AERUGINOSA
Fig. 3. Nucleotide sequence of de novel IS3-like element, ISPa133, present in strain PA110514 and its proposed derivative PA116136. The underlined
sequences represent the 25-bp inverted repeats (IRs). Bold letters within the IRs indicate mismatches between left and right IRs. Translational start and stop
codons of both orfs encoded by the mobile element are boxed; the amino acid sequence of the two open reading frames are shown below the sequence.
Shaded regions represent the sequence of the oprD gene flanking the IS element. 
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ing the first 222 amino acids of the porin, but in PAFL4 and
in the rest of resistant strains, it was located just before
nucleotide 703, causing the removal of the first 234 amino
acids of OprD (Fig. 4).
Discussion
Carbapenems are a class of β-lactam antibiotics with good
antimicrobial activity against P. aeruginosa; as such, they are
often used as a last resort in infections due to multidrug-
resistant strains of the bacterium [21]. However, the emer-
gence and spread of acquired carbapenem resistance have
challenged therapeutic and control efforts [5], necessitating a
better understanding of the molecular mechanisms underly-
ing resistance. Moreover, it seems likely that several mecha-
nisms are involved in carbapenem resistance [7]. 
The two clinical isolates of this study, PA110514 and
PA116136, were identical in their PFGE profiles and in bio-
chemical tests, suggesting their close relationship. The
unique noticeable difference between the isolates was in their
susceptibility to imipenem. Our hypothesis, that this differ-
ence involved the OMPs, was supported by the results of
SDS-PAGE, which revealed the loss of OprD in PA116136
(Fig. 1) and suggested that this strain was a PA110514 deriv-
ative. To investigate the mechanism responsible for the loss
of the porin, the oprD gene of each strain was amplified and
sequenced. Examination of these sequences revealed the
presence of a new insertion sequence, ISPa133, located 56
nucleotides upstream of the oprD start codon in PA110514.
However, since this isolate is imipenem-susceptible, the
presence of ISPa133 has no obvious effect on the upstream
regulatory region of the gene, as oprD expression was normal
(Fig. 1) as was the expression of the porin OprD. By contrast,
in PA116136, the insertion element (99% identity) is located
immediately before nucleotide position 696, which causes
the removal of the first 232 amino acids of OprD.
Consequently, the protein is not expressed and was not
detectable in the gels (Fig. 1). Since loss of the protein pre-
vents the entrance of imipenem, strain PA116136 is resistant
to the antibiotic.
To date, the presence of ISs in OprD has been reported
only once , although these elements have been detected in
other genes of P. aeruginosa [3,4,28]. In those cases, the ISs
were described in resistant isolates and thus assumed to be
the cause of resistance, either via gene activation or by induc-
ing the high level expression of a potential resistance gene.
Based on the findings in the two clinical isolates analyzed in
this study, we propose that the newly identified insertion ele-
ment ISPa133 acts as a switch, depending on the degree of
selective pressure exerted by imipenem. In the absence of
selective pressure, as was the case during isolation of strain
PA110514 from an infected, untreated patient, OprD is found
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Fig. 4. Schematic diagram of the locations of the ISPa133 element with respect to the oprD gene. The solid arrow represents the oprD
structural gene while the striped arrow represents ISPa133.
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on the OM and the position of ISPa133 in the genome has no
effect on oprD expression; however, selective pressure exerted
by antibiotic therapy results in the selection of strains in
which ISPa133 moves within the oprD gene, such that, in the
case of strain PA116136, the first 232 amino acids are
removed, thus preventing expression of the gene. A high rate
of ISPa133 jumping would therefore provide a major selec-
tive advantage, one that allows the bacterium to survive in
the presence of carbapenems.
It has been proposed that ISs without DRs may simply
result from the homologous inter- or intra-molecular recom-
bination between two IS elements, each with a different DR
sequence, or from the formation of adjacent deletions arising
from duplicative intramolecular transposition [35]. For
ISPa133, this could explain the lack of DRs as well as the
absence of a crossover region between orfA and orfB.
As shown in other species, experiments mimicking natu-
ral conditions can provide insight into population phenome-
na [19]. This was the aim of our experiments in which strain
PA110514 was submitted to selective pressure by imipenen
in culture flasks in order to obtain spontaneous resistant
mutants in vitro with properties similar or identical to those
of the strains isolated from a patient hospitalized with a P. ae-
ruginosa infection. Indeed, mutants with levels of resistance
similar to those of strain PA116136 were easily recovered.
Moreover, when the experiments were prolonged, the MICs
of the isolates were even higher (16 μg/ml). 
Note that, according to the above-proposed mechanism of
action, removal of the selective pressure exerted by the
antibiotic should restore bacterial susceptibility to carbapen-
ems through the expression of the full-length OprD; whether
this is the case remains to be determined. However, this
change would not be expected to occur as quickly as the
acquisition of resistance, since the selective advantage con-
ferred by imipenem resistance in the presence of the antimi-
crobial is severe whereas OprD expression is likely to be
evolutionarily advantageous only under certain environmen-
tal conditions. 
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